What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.81%Above 5Y avg (0.48%)
Annual Rate
TRY 0.03Paid semi-annual
Payout Ratio
7.1%Sustainable
Last Ex-Dividend
Aug 4, 2026
The reported statements, read against the company's own industry.
What stands out
Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
17.96BTRY
357.61M · vs all stocks (USD)
Updated Oct 25, 2026
Trailing P/E
15.32x
Updated Oct 25, 2026
Revenue (TTM)
22.17BTRY
441.35M · vs all stocks (USD)
Updated Oct 25, 2026
Profit Margin
5.21%
Updated Oct 25, 2026
Beta
-0.0270x
vs all stocks
Updated Oct 25, 2026
52-Week Change
-67.93%
vs all stocks
Updated Oct 25, 2026
Forward Annual Dividend Yield
0.81%
vs all stocks
Updated Oct 25, 2026
Market Capitalization
17.96BTRY
357.61M · vs all stocks (USD)
Updated Oct 25, 2026
Enterprise Value
23.17BTRY
461.41M · vs all stocks (USD)
Updated Oct 25, 2026
Trailing P/E
15.32x
Updated Oct 25, 2026
PEG Ratio
0.0288x
Updated Oct 25, 2026
Price to Sales (TTM)
0.7758x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.81×.Updated Oct 25, 2026
Price to Book (MRQ)
1.32x
Updated Oct 25, 2026
Enterprise to Revenue
1.04x
Updated Oct 25, 2026
Enterprise to EBITDA
7.92x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 7×.Updated Oct 25, 2026
Gross Margin
21.33%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 23.64%.Updated Oct 25, 2026
Profit Margin
5.21%
Updated Oct 25, 2026
Operating Margin
10.98%
Updated Oct 25, 2026
Return on Assets (TTM)
7.99%
Updated Oct 25, 2026
Return on Equity (TTM)
10.46%
Updated Oct 25, 2026
Revenue (TTM)
22.17BTRY
441.35M · vs all stocks (USD)
Updated Oct 25, 2026
Revenue per Share (TTM)
4.13TRYUpdated Oct 25, 2026
Quarterly Revenue Growth
22.90%
Updated Oct 25, 2026
Gross Profit (TTM)
5.24BTRY
104.35M · vs all stocks (USD)
Updated Oct 25, 2026
EBITDA (TTM)
3.31BTRY
65.92M · vs all stocks (USD)
Updated Oct 25, 2026
Net Income (TTM)
1.16BTRY
23.01M · vs all stocks (USD)
Updated Oct 25, 2026
Quarterly Earnings Growth (YoY)
377.10%
Updated Oct 25, 2026
Operating Cash Flow (TTM)
1.29BTRY
25.69M · vs all stocks (USD)
Updated Oct 25, 2026
Levered Free Cash Flow (TTM)
-4.38BTRY
-87.30M · vs all stocks (USD)
Updated Oct 25, 2026
Forward Annual Dividend Rate
0.0323TRYUpdated Oct 25, 2026
Forward Annual Dividend Yield
0.81%
vs all stocks
Updated Oct 25, 2026
Trailing Annual Dividend Rate
0.0250TRYUpdated Oct 25, 2026
Trailing Annual Dividend Yield
0.63%
vs all stocks
Updated Oct 25, 2026
5-Year Average Dividend Yield
0.48%
vs all stocks
Updated Oct 25, 2026
Payout Ratio
7.11%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 10.01%.Updated Oct 25, 2026
Minority Interest (Equity)
-6.85MTRYFY2025 · Dec 31, 2025
Revenue
19.18BTRYFY2025 · Dec 31, 2025
Cost of Goods Sold
15.16BTRYFY2025 · Dec 31, 2025
Gross Profit
4.02BTRYFY2025 · Dec 31, 2025
Operating Income
2.36BTRY
46.95M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
1.49BTRYFY2025 · Dec 31, 2025
Income Tax Expense
680.24MTRYFY2025 · Dec 31, 2025
Net Income
805.68MTRYFY2025 · Dec 31, 2025
EBIT
2.41BTRYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
2.76BTRYFY2025 · Dec 31, 2025
Research & Development
685.71MTRYFY2025 · Dec 31, 2025
Selling, General & Administrative
777.53MTRYFY2025 · Dec 31, 2025
Other Operating Expenses
466.66MTRYFY2025 · Dec 31, 2025
Non-operating Interest Income
573.54MTRYFY2025 · Dec 31, 2025
Non-operating Interest Expense
921.34MTRYFY2025 · Dec 31, 2025
EPS (Basic)
0.1519TRYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1519TRYFY2025 · Dec 31, 2025
Basic Shares Outstanding
5.36BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
5.36BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
814.44MTRYFY2025 · Dec 31, 2025
Minority Interests (P&L)
8.76MTRYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00TRYFY2025 · Dec 31, 2025
Operating Cash Flow
619.34MTRYFY2025 · Dec 31, 2025
Free Cash Flow
617.74KTRYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
93.97MTRYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
814.44MTRYFY2025 · Dec 31, 2025
Other Non-cash Items
464.22MTRYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-213.68MTRYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-445.64MTRYFY2025 · Dec 31, 2025
Capital Expenditures
-618.72MTRYFY2025 · Dec 31, 2025
Net Intangibles (CF)
-365.70MTRYFY2025 · Dec 31, 2025
Other Investing Activity
-314.56KTRYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-619.03MTRYFY2025 · Dec 31, 2025
Other Financing Charges
2.64MTRYFY2025 · Dec 31, 2025
Net Financing Cash Flow
2.64MTRYFY2025 · Dec 31, 2025
Shares Outstanding
4.49BSharesUpdated Oct 25, 2026
Float Shares
298.57MSharesUpdated Oct 25, 2026
% Held by Insiders
74.94%
vs all stocks
Updated Oct 25, 2026
% Held by Institutions
1.72%
vs all stocks
Updated Oct 25, 2026
Total Cash (MRQ)
228.89MTRY
4.56M · vs all stocks (USD)
Updated Oct 25, 2026
Total Cash per Share (MRQ)
0.0510TRYUpdated Oct 25, 2026
Total Debt (MRQ)
5.32BTRY
106.00M · vs all stocks (USD)
Updated Oct 25, 2026
Total Debt to Equity (MRQ)
0.4079x
Updated Oct 25, 2026
Current Ratio (MRQ)
1.29x
Updated Oct 25, 2026
Book Value per Share (MRQ)
2.90TRYUpdated Oct 25, 2026
Total Assets
19.45BTRY
387.26M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
9.87BTRYFY2025 · Dec 31, 2025
Total Liabilities
9.12BTRYFY2025 · Dec 31, 2025
Total Non-current Assets
9.58BTRYFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.35BTRYFY2025 · Dec 31, 2025
Total Current Liabilities
7.77BTRYFY2025 · Dec 31, 2025
Cash
75.96MTRYFY2025 · Dec 31, 2025
Cash Equivalents
18.01MTRYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
93.97MTRYFY2025 · Dec 31, 2025
Other Short-term Investments
2.04BTRYFY2025 · Dec 31, 2025
Accounts Receivable
2.08BTRYFY2025 · Dec 31, 2025
Inventory
2.34BTRYFY2025 · Dec 31, 2025
Accounts Payable
3.18BTRYFY2025 · Dec 31, 2025
Short-term Debt
2.90BTRYFY2025 · Dec 31, 2025
Long-term Debt
239.83MTRYFY2025 · Dec 31, 2025
Common Stock (Book)
4.50BTRYFY2025 · Dec 31, 2025
Retained Earnings
3.52BTRYFY2025 · Dec 31, 2025
Total Shareholders' Equity
10.33BTRY
205.65M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
93.21MTRYFY2025 · Dec 31, 2025
52-Week Low
3.49TRYUpdated Oct 25, 2026
52-Week High
13.52TRYUpdated Oct 25, 2026
52-Week Change
-67.93%
vs all stocks
Updated Oct 25, 2026
Beta
-0.0270x
vs all stocks
Updated Oct 25, 2026
50-Day MA
8.49TRYUpdated Oct 25, 2026
200-Day MA
9.02TRYUpdated Oct 25, 2026
Avg 10-Day Volume
116.26MSharesUpdated Oct 25, 2026
Avg 30-Day Volume
95.35MSharesUpdated Oct 25, 2026
Diluted EPS (TTM)
0.2500TRYUpdated Oct 25, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.23Receivables vs revenue divergence: 7.28